Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention-Reference-Cited by-同舟云学术

Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention

Published:2015-11 Issue:11 Volume:108 Page:554-562
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

Loncar Goran,Barthelemy Olivier,Berman Emmanuel,Kerneis Mathieu,Petroni Thibault,Payot Laurent,Choussat Remi,Silvain Johanne,Collet Jean-Philippe,Helft Gérard,Montalescot Gilles,Le Feuvre Claude

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference28 articles.

1. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn?. Where do we go from here?. National Kidney Foundation Task Force on Cardiovascular Disease;Levey;Am J Kidney Dis,1998

2. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease;Sedlis;Am J Cardiol,2009

3. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study);Dumaine;Am J Cardiol,2004

4. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes;Al Suwaidi;Circulation,2002

5. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions;Best;J Am Coll Cardiol,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of low-density lipoprotein level and mortality in older incident statin-naïve hemodialysis patients;BMC Nephrology;2023-10-02

2. Disorders of lipid metabolism. Clinical Guidelines 2023;Russian Journal of Cardiology;2023-06-03

3. Guía ESC/EAS 2019 sobre el tratamiento de las dislipemias: modificación de los lípidos para reducir el riesgo cardiovascular;Revista Española de Cardiología;2020-05

4. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk;Atherosclerosis;2019-11

5. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;European Heart Journal;2019-08-31